| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 06/27/2007 | EP1343779B1 Novel compounds |
| 06/27/2007 | EP1305419B1 Modulation by il-tif/interleukin-21 |
| 06/27/2007 | EP1301485B1 Novel heteroaryl derivatives and the use thereof as pharmaceuticals |
| 06/27/2007 | EP1284973B1 Inhibitors of alpha l beta 2 mediated cell adhesion |
| 06/27/2007 | EP1047676B1 Substituted 11-phenyl-dibenzazepine compounds useful for the treatment or prevention of diseases characterized by abnormal cell proliferation |
| 06/27/2007 | EP0954340B1 Targeted combination immunotherapy of cancer |
| 06/27/2007 | EP0863903B1 Synthetic metal-substituted bacteriochlorophyll derivatives and use thereof |
| 06/27/2007 | CN1989245A Novel galectin 8 modification protein and use thereof |
| 06/27/2007 | CN1989146A Sulfated oligosaccharide derivatives |
| 06/27/2007 | CN1989131A Substituted thiophene derivatives as anti-cancer agents |
| 06/27/2007 | CN1989122A Novel cylopenta[b]benzofuran derivatives and the utilization thereof |
| 06/27/2007 | CN1988934A Tetrahydropyridothiophenes |
| 06/27/2007 | CN1988911A A method for preparing purified extract from wild ginseng showing anticancer activity and the composition comprising the same |
| 06/27/2007 | CN1988904A Epothilone combinations |
| 06/27/2007 | CN1988901A Pharmaceutical products for treating neoplastic disease and inflammation |
| 06/27/2007 | CN1988894A Preventive for the onset of liver cancer comprising quinone compound as the active ingredient |
| 06/27/2007 | CN1987465A Immune fluorescence grouping method |
| 06/27/2007 | CN1986826A Holathuria nobilis polyose extracting process and its medicinal use |
| 06/27/2007 | CN1986560A Preparing process and antitumor use of compound Ananaside C |
| 06/27/2007 | CN1986559A Preparing process and antitumor use of compound Ananaside B |
| 06/27/2007 | CN1986549A Tumor-targeting dendritic macromolecular paramagnetic metal complex and its synthesis process and use |
| 06/27/2007 | CN1986546A Geldanamycin derivative and its preparing method and use |
| 06/27/2007 | CN1986543A Cancer chemotherapy |
| 06/27/2007 | CN1985997A Degradable radioactive sponge and its making process |
| 06/27/2007 | CN1985994A Improved enteric medicine composition with mycophenolate |
| 06/27/2007 | CN1985990A Composition and application of novel medicine package for preventing and treating women's cervical virus infection |
| 06/27/2007 | CN1985981A Chinese medicine composition for treating cancers and other diseases |
| 06/27/2007 | CN1985977A Zedoary oil leaching process from zedoary powder with petroleum ether |
| 06/27/2007 | CN1985973A Abdomen mass eliminating Jinci medicine powder tumor Chinese medicine preparation fortreating |
| 06/27/2007 | CN1985963A Medicine for treating organ cyst and its preparing method |
| 06/27/2007 | CN1985960A Slow released capsule of clarithromycin and bletilla tuber glue for animal and birs |
| 06/27/2007 | CN1985943A Extraction process of aloe gel concentrate |
| 06/27/2007 | CN1985937A Medicine for treating hepatic duct tumor and its preparing method |
| 06/27/2007 | CN1985895A Medicine composition for treating tumor |
| 06/27/2007 | CN1985894A Chinese medicine for regulating body's immunity of tumor patient |
| 06/27/2007 | CN1985889A Chinese herbal medicine for treating cancer |
| 06/27/2007 | CN1985877A Astragalus extract and its medicine use |
| 06/27/2007 | CN1985876A Application of astragalus flavonid in preparing antitumor medicine |
| 06/27/2007 | CN1985860A Matter with antitumor activity and its medicine preparation |
| 06/27/2007 | CN1985853A No-cell calmette-Guerin bacillus mucosa immune regulator and its application |
| 06/27/2007 | CN1985852A Process of extracting sea cucumber polyose and other active components from boiled sea cucumber juice |
| 06/27/2007 | CN1985851A Lipoid microsphere injection containing toad cake extract and its preparing method |
| 06/27/2007 | CN1985818A Selenophen compound for treating cancer and its medicine composition |
| 06/27/2007 | CN1985817A Cnidiadin liposome and its preparing process and application |
| 06/27/2007 | CN1323080C Pyrimido compounds having antiproliferative activity |
| 06/27/2007 | CN1322899C Anti cancer gene medicinal composition, micromolecule interfere RNA and its filtrate method |
| 06/26/2007 | USRE39707 Camptothecin derivatives |
| 06/26/2007 | USRE39706 Crystalline form of a vitamin D analogue |
| 06/26/2007 | US7235695 Cycloalkyl substituted polyamines for cancer therapy and methods of synthesis therefor |
| 06/26/2007 | US7235689 Hydroxamic acid derivatives having anti-inflammatory action |
| 06/26/2007 | US7235685 Of tumors and other lesions; phototherapeutic effect is caused by direct interaction of free radicals, the reactive intermediate produced upon photofragmentation of the sulfenate moiety, with the tissue of interest |
| 06/26/2007 | US7235667 N-phenylarylsulfonamide compound, pharmaceutical composition comprising the compound as active ingredient, synthetic intermediate for the compound and process for its preparation |
| 06/26/2007 | US7235658 Imidazol derivatives as Raf kinase inhibitors |
| 06/26/2007 | US7235635 IRAK-4: compositions and methods of use |
| 06/26/2007 | US7235634 Comprises proteolytic enzymes for use as tools to identify modulators for treatment and prevention of gastrointestinal, cell proliferative and inflammatory diseases |
| 06/26/2007 | US7235585 Enzyme activated self-immolative n-substituted nitrogen mustard prodrugs |
| 06/26/2007 | US7235578 Used as cytotoxins for cancer therapy and as prodrugs for gene-directed enzyme-prodrug therapy and antibody-directed enzyme-prodrug theraphy |
| 06/26/2007 | US7235567 Crystalline polymorph of a bisulfate salt of a thrombin receptor antagonist |
| 06/26/2007 | US7235565 Quinoline and quinolinones 4-substituted with a 3-(hetero)cyclylcarbonyl-1-imidazolinyl or 3-(hetero)cyclylcarbonyl-1-imidazolinonyl group; treating diabetes, glomerulonephritis, endotoxic shock, psoriasis, and arthritis |
| 06/26/2007 | US7235564 11'-substituted; potent inhibitors of cellular mitosis and proliferation |
| 06/26/2007 | US7235562 5-trifluoromethyl-N2-indolyl- and quinolinyl-substituted-2,4-pyrimidinediamines, e.g., N2-[3-(1,2,3,6-Tetrahydro-pyridin-4-yl)-1H-indol-5-yl]-N4-p-tolyl-5-trifluoromethyl-pyrimidine-2,4-diamine and -[4-(3-Methanesulfonyl-benzylamino)-5-trifluoromethyl-pyrimidin-2-ylamino]-3,4-dihydro-1H-quinolin-2-one |
| 06/26/2007 | US7235561 Compound and a composition including such a compound |
| 06/26/2007 | US7235559 Therapeutic quinazoline derivatives |
| 06/26/2007 | US7235557 Benzo-1,5-naphthyridine and benzo-2,5-naphthyridine derivatives are used as poly(ADP-ribose) polymerase inhibitors for treating vascular stroke, cerebral ischemia, heart ischemia/reperfusion injury and gout |
| 06/26/2007 | US7235555 Indolylmaleimide derivatives |
| 06/26/2007 | US7235554 Water soluble; treating diseases in which peripheral benzodiazepine receptors are involved such as spinal amyotrophy, amyotrophic lateral sclerosis, cranial and medullar trauma, multiple sclerosis, and diabetic nephropathy |
| 06/26/2007 | US7235552 Cholenic acid amides and pharmaceutical compositions thereof |
| 06/26/2007 | US7235550 Polycyclic azaindole compounds |
| 06/26/2007 | US7235549 Benzamide, heteroarylamide and reverse amides |
| 06/26/2007 | US7235546 Therapeutic treatment of diabetes with a 4-[piperazine-1-yl]-1,2-dihydro-quinolines; treating tumor growth, glomerulonephritis, inflammation, malarial anemia, septic shock, tumor associated angiogenesis, vitreoretinopathy, psoriasis, graft versus host disease, atopic dermatitis |
| 06/26/2007 | US7235523 Methods for the treatment of hepatic disorders |
| 06/26/2007 | US7235403 Culturing a cell in the presence or absence of the compound, assaying the cell for expression or activity of gene(s), detecting the compound when expression of the genes is lower in the presence of the compound than in the absence |
| 06/26/2007 | US7235371 Human osteoclast derived cathepsin |
| 06/26/2007 | US7235365 Specific binding agents for KSHV vIL-6 that neutralize a biological activity |
| 06/26/2007 | US7235262 Use of bioactive fraction from cow urine distillate (‘Go-mutra’) as a bio-enhancer of anti-infective, anti-cancer agents and nutrients |
| 06/26/2007 | CA2307792C Method for regulating size and growth of vascularized normal tissue |
| 06/26/2007 | CA2265464C Therapy for .alpha.-galactosidase a deficiency |
| 06/26/2007 | CA2235686C Indolin-2-one derivatives, process for their production and the pharmaceutical compositions containing them |
| 06/26/2007 | CA2215372C Bicyclic tachykinins antagonists, preparation thereof and their use in pharmaceutical composition |
| 06/26/2007 | CA2186423C Protein which induces interferon-gamma production by immunocompetent cell |
| 06/26/2007 | CA2155014C Process for the preparation of baccatin iii analogs bearing new c2 and c4 functional groups |
| 06/21/2007 | WO2007070872A1 Kinase inhibitors and their uses |
| 06/21/2007 | WO2007070623A2 Transcatheter tumor immunoembolization |
| 06/21/2007 | WO2007070514A1 Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors |
| 06/21/2007 | WO2007070444A1 Lestaurtinib crystalline form 1, crystalline lestaurimib anhydrate and amorphous lestaurimib |
| 06/21/2007 | WO2007070398A1 Polycyclic indazole derivatives that are erk inhibitors |
| 06/21/2007 | WO2007070319A2 Dibenzonaphthyridine derivatives and methods of use thereof |
| 06/21/2007 | WO2007069977A1 Alkylsulphonamide quinolines |
| 06/21/2007 | WO2007069924A1 Deazapurine analogs of 4'-aza-l-nucleosides |
| 06/21/2007 | WO2007069923A1 Deazapurine analogs of 1'-aza-l-nucleosides |
| 06/21/2007 | WO2007069795A1 Method for prevention of tumor |
| 06/21/2007 | WO2007069709A1 Detecting agent and therapeutic agent for highly malignant breast cancer |
| 06/21/2007 | WO2007069635A1 Vla-4 inhibitory drug |
| 06/21/2007 | WO2007069368A1 Peptides originating in hepatitis c virus |
| 06/21/2007 | WO2007068963A2 Therapeutic compositions comprising ingenol-3-angelate |
| 06/21/2007 | WO2007068905A1 1,2,4-TRIAZOL-l-YL BISPHENYL DERIVATIVES FOR USE IN THE TREATMENT OF ENDOCRINE-DEPENDENT TUMOURS |
| 06/21/2007 | WO2007068895A1 Combination of angiopoietin-2 antagonist and of vegf-a, kdr and/or flt1 antagonist for treating cancer |
| 06/21/2007 | WO2007068776A1 Antitumour compounds |
| 06/21/2007 | WO2007068728A2 N-substituted pyrrolopyridinones active as kinase inhibitors |
| 06/21/2007 | WO2007068678A1 Process for the preparation of 3-pyridyl-1-hydroxyethylidene-1,1-biphosphonic acid and hydrated forms thereof |